MedPath
FDA Approval

Xopenex

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
December 1, 2010
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levosalbutamol(1.25 mg in 3 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Rebel Distributors Corp

Rebel Distributors Corp

118802834

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Xopenex

Product Details

NDC Product Code
21695-153
Application Number
NDA020837
Marketing Category
NDA (C73594)
Route of Administration
RESPIRATORY (INHALATION)
Effective Date
June 3, 2010
Code: WDQ1526QJMClass: ACTIBQuantity: 1.25 mg in 3 mL
sodium chlorideInactive
Code: 451W47IQ8XClass: IACT
sulfuric acidInactive
Code: O40UQP6WCFClass: IACT
waterInactive
Code: 059QF0KO0RClass: IACT
nitrogenInactive
Code: N762921K75Class: IACT
© Copyright 2025. All Rights Reserved by MedPath